Sun Pharmaceutical Industries Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹14,611.79 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 5.86 per cent from ₹15,520.54 crore. This corresponds to a year-on-year *(YoY) growth of 12.76 per cent.
Operating Profit
Operating Profit stands at ₹3,954.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.32 per cent from ₹4,459.01 crore. This corresponds to a year-on-year *(YoY) growth of 17.88 per cent.
PBDT
PBDT stands at ₹4,312.75 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.69 per cent from ₹4,939.57 crore. This corresponds to a year-on-year *(YoY) growth of 10.26 per cent.
Profit Before Tax
Profit Before Tax stands at ₹3,537.28 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 15.92 per cent from ₹4,207.24 crore. This corresponds to a year-on-year *(YoY) growth of 8.92 per cent.
Net Profit
Net Profit stands at ₹2,709.66 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 19.86 per cent from ₹3,381.17 crore. This represents a 25.80 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Sun Pharmaceutical Industries Ltd News
Sun Pharmaceutical Industries Ltd Earnings
- YOY
- QOQ
Sun Pharmaceutical Industries Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Sun Pharmaceutical Industries Ltd Research Reports
Sun Pharmaceutical Industries Ltd Financial Reports
Sun Pharmaceutical Industries Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | -0.67% | -1.08% | 3.65% | 11.06% | 20.55% | 13.98% |
| Divi's Lab. | -0.89% | -1.14% | 10.43% | 12.63% | 16.82% | 10.16% |
| Torrent Pharma. | -1.35% | -1.57% | 6.43% | 18.56% | 25.37% | 36.82% |
| Cipla | 1.23% | -1.51% | -2.93% | 7.86% | 6.22% | -10.19% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Dilip S Shanghvi
Executive Director & MD : Kirti Wardhaman Ganorkar
Lead Independent Non Executive Director : Pawan Goenka
Independent Non Exe. Director : Gautam Doshi
Independent Non Exe. Director : Rolf Hoffmann
ED / WTD / CFO / Promoter : AALOK DILIP SHANGHVI
E D & Wholetime Director : Vidhi Shanghvi
Independent Non Exe. Director : Satyavati Berera
Independent Non Exe. Director : Andreas Busch
Company Sec. & Compli. Officer : ANOOP ANJANIKUMAR DESHPANDE